You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Greece

Mar 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Greece with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Greece, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Greece for free:

The Consumer Health in Greece market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Greece?
  • What are the major brands in Greece?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Confusion and price declines squeeze value sales

Consumer health value sales saw a considerable decline in 2010, mainly due to price-related issues. For a good part of the year, until the official price list was published in September 2010, manufacturers and pharmacists were in a state of confusion regarding the future state of prices; as a result, pharmacists destocked, waiting for lower prices to be imposed, whilst manufacturers were unmotivated to make switches or new product launches. Moreover, sharp price decreases across a wide range of products imposed in May 2010, as well as the new, low prices finally imposed in September, which according to the new regulation were calculated as the average of the three lowest prices in the Eurozone, had an adverse effect on value sales. However, despite the new low prices, the market started to stabilise and recover after the price list was published in September.

Official list of over-the-counter drugs finally published

In May 2010, the Greek Ministry of Health published an official list of over-the-counter drugs, responding to a long-standing demand for the industry. The new list helps in the clear categorisation of OTC drugs. All products included in the list can only be sold through chemists and pharmacists, and will no longer be reimbursed and can be advertised; yet their prices remain controlled by the state. Industry officials are disappointed by the fact that prices are still under state control, as this provides a countermotive for innovation and new product development, but they believe that the cessation of reimbursement is the first step towards the industry’s most prominent demand, the liberation of the prices of over-the-counter drugs, as is the case in most European countries.

Scepticism and loyalty continue to hinder new entrants

Consumer health continued to be led by established brands and players such as Novartis (Hellas) SACI and Power Health Hellas SA. In terms of company activity, consumer health was rather stagnant, whilst new entrants only came from herbal/traditional products. Most of the brands within Greek consumer health are long-time trusted names, as Greeks seem less inclined to experiment with products when it comes to healthcare. This naturally led to little fluctuation in terms of value shares, as consumers remained largely loyal to the brands they find most effective or have simply grown accustomed to purchasing.

Future performance will depend on pricing policy

Forecast performance of consumer health in Greece will largely depend on state policy as regards pricing of over-the-counter products. If prices remain state-controlled, and thus at rather low levels, consumer health value sales will stagnate. If prices are liberated, which is very possible after 2012, value sales will see healthy growth, as switches and new product developments will occur, and manufacturers will invest more on promotion and advertising.

Table of Contents

Table of Contents

Consumer Health in Greece - Industry Overview

EXECUTIVE SUMMARY

Confusion and price declines squeeze value sales

Official list of over-the-counter drugs finally published

Scepticism and loyalty continue to hinder new entrants

Future performance will depend on pricing policy

KEY TRENDS AND DEVELOPMENTS

Uncertainty and low, state-controlled prices arrest development

Cessation of state reimbursements has negative impact on sales

Current health trends favour herbal/traditional products, but recession restrains growth

Merging health and beauty trends impact healthcare

Recession, austerity measures and growing price awareness

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Penetration of Private Label by Category 2005-2010
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and dietary supplements registration and classification

Self-medication and preventative medicine

Switches

  • Summary 1 OTC Healthcare Switches 2008-2010

DEFINITIONS

  • Summary 2 Research Sources

Consumer Health in Greece - Company Profiles

ApiVita SA - Consumer Health - Greece

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Summary ApiVita SA: Competitive Position 2010

Korres Natural Products SA - Consumer Health - Greece

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Korres Natural Products SA: Competitive Position 2010

Power Health Hellas SA - Consumer Health - Greece

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 11 Power Health Hellas SA: Competitive Position 2010

Sarantis SA, Gr - Consumer Health - Greece

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 14 Gr Sarantis SA: Competitive Position 2010

Uni-Pharma SA - Consumer Health - Greece

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 17 Uni-Pharma SA: Competitive Position 2010

Adult Mouth Care in Greece - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care saw its value sales decline by 4% in 2010, hit by the current economic crisis and shrinking disposable income. Adult mouth care products are considered as nonessential purchases and therefore financially strained consumers were keen to cut down on relative expenditure. Furthermore, shrinking disposable income may also have forced consumers to pay fewer visits to the dentist, who is in most cases the one who advises the use of mouth care products. Thus, despite the review period trend which favoured consumption for precautionary reasons, the category declined.

COMPETITIVE LANDSCAPE

  • Adult mouth care in Greece remains relatively focused around a few leading brands and companies. Janssen-Cilag Pharmaceutical continued to lead the category in 2010, mainly due to the popularity of its leading brand Hexalen which claimed a share of 40%. Hexalen became a recognised brand in the area of mouth care in Greece largely due to widespread recommendation by doctors and recognition amongst consumers for its relief of discomfort caused by many mouth ailments.

PROSPECTS

  • As the economic situation in Greece is not expected to improve during the forecast period – on the contrary, it is most likely to deteriorate – consumers will remain very cost-wary. In this context, there will be intense price competition, narrowing profit margins for pharmacies.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2005-2010
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 14 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 15 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Greece - Category Analysis

HEADLINES

TRENDS

  • The new list of OTC drugs that was published by the Greek Ministry of Health in May 2010 and included the vast majority of analgesics, impacted analgesics negatively, as it dictated that OTC drugs would no longer be reimbursed by the state. In effect, consumers had to pay for 100% of the product’s price, whereas before May 2010 they only had to pay for 25%, with the state reimbursing the rest. This had a negative impact on volume sales across the whole category of analgesics; within analgesics, where acetaminophen is still dominant, the trend towards ibuprofen, mainly at the expense of aspirin, remained strong throughout 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bristol-Myers Squibb SA continued to lead analgesics with a 19% share of value sales. Of this, 16% was attributed to popular acetaminophen brand Depon and the other 3% was based on the sales of Counterpain in topical analgesics/anaesthetic. Depon continued to be the leading brand in acetaminophen in 2010, having achieved wide recognition with its long presence in the category, whilst it continued to succeed in satisfying demands by keeping a variety of products in terms of format, pack and dosage. At the same time, Counterpain is again highly recognised and also maintained its third position in value share of topical analgesics/anaesthetic. Counterpain was the second best-selling topical analgesic in creams after Voltaren Emulgel.

PROSPECTS

  • Consumer trends at the end of the review period showed a preference for products which offered rapid or “instant” pain relief. This trend developed as a result of the increasingly busy pace of everyday life in Greece, which saw consumers looking for a quick fix when they encountered pain. Products which promote rapid pain relief are therefore likely to be growth drivers over the forecast period. Other products which look set to target this increasingly busy pace of life in Greece are also likely to become more common, for example products which offer ease of consumption such as Depon Odis, which can be consumed without water. Continued segmentation of analgesics into products which offer specific pain relief will also play an important role over the forecast period by speeding up the process of selecting the required product for consumers. In the case of topical analgesics, in line with the increasing demand for convenience, cream/gel format products are expected to keep increasing share at the expense of patches.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2005-2010
  • Table 19 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 21 Analgesics Company Shares by Value 2006-2010
  • Table 22 Analgesics Brand Shares by Value 2007-2010
  • Table 23 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Greece - Category Analysis

HEADLINES

TRENDS

  • Calming and sleeping products in Greece achieved positive retail value growth of 3% in 2010, reaching €3 million. Increasing stress and insomnia levels, associated with the pace of life for the average contemporary Greek consumer, as well as the severe economic downturn and uncertainty, led more and more consumers to try calming and sleeping products. In addition, consumers increasingly prefer products that confront stress without causing sleepiness or addiction.

COMPETITIVE LANDSCAPE

  • The variety of companies and brands operating in calming and sleeping products in Greece remained minimal in 2010, with no changes compared to the previous year. The leading player in Greece during the review period was Gr Sarantis SA with its brand Quiet Life. Quiet Life enjoys a high level of brand awareness amongst Greeks, securing a retail value share of 43% in 2010 for Gr Sarantis SA.

PROSPECTS

  • Calming and sleeping products is expected to continue to see positive retail value growth at a 1% CAGR over the forecast period. Economic instability and high levels of unemployment in Greece are likely to result in increased cases of stress and insomnia amongst Greek consumers over the forecast period. As well as this, the increasing pace of everyday life in Greece is not expected to stall in the forecast period, resulting in an increase in demand for calming and sleeping products. As consumers are overcoming taboos related with the use of such products, the penetration of the category is increasing.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2005-2010
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 27 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 28 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Greece - Category Analysis

HEADLINES

TRENDS

  • After the boost given to the category in 2009 due to the H1N1 outbreak, 2010 was a year of decline. Cough, cold and allergy remedies saw value sales decline by 1%. One reason was the milder winter, which did not favour the outbreak of cold or flu incidents. Furthermore, the waiting for the new, reduced price list caused many pharmacists to destock, often creating shortages in the market. Finally, the new prices announced in 2010 were lower in most cases, leading value sales down.

SWITCHES

COMPETITIVE LANDSCAPE

  • Medicated confectionery is one of the few categories in consumer health in Greece in which products are mainly distributed via grocery retailers and street kiosks. As a result of this, products in medicated confectionery are easy to find at all times and are rarely perceived as pharmaceutical products amongst consumers. Ranked first within this category, Cadbury Hellas managed to claim a 32% value share of all cough, cold and allergy (hay fever) remedies in Greece. No significant changes occurred as regards the ranking of manufacturers in 2010.

PROSPECTS

  • The current legislative status, according to which OTC products can be advertised, but their prices are state-controlled, does not allow for significant developments in the category. In this Rx-driven market, a potential liberation of prices, much anticipated by industry officials, would pave the way for switches and new product developments, which would drive value growth. However, until this happens, cold, cough and allergy (hay fever) remedies as a whole is set to see small value CAGR of 2% over the forecast period.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 33 Sales of Decongestants by Category: Value 2005-2010
  • Table 34 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 36 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Greece - Category Analysis

HEADLINES

TRENDS

  • In line with previous years, 2010 saw a lot of media coverage on the increasing levels of poor dietary habits amongst Greek consumers. Over the review period, the pace of life in Greece increased rapidly and as a result many consumers found themselves with less and less time to prepare meals of a decent quality. As a result, the diets of contemporary Greek consumers now contain higher levels of fat, sugar and processed ingredients, all of which contribute to digestive problems. Whilst this trend boosts demand for digestive remedies, the exclusion of OTC drugs from state reimbursement counterbalances this increase, leading to lower volume growth.

SWITCHES

COMPETITIVE LANDSCAPE

  • Aventis Pharma (Venezuela) SA continued to be the leading company in digestive remedies in 2010, with a retail value share of 29%. The company’s strong position is due to its popular Maalox antacid, which enjoys high levels of recognition and trust amongst Greek consumers, and is in many cases used as a byword for antacids.

PROSPECTS

  • The biggest threat to potential forecast growth comes from current health and wellness trends which are gathering pace in Greece. The Greek government is very aware that the eating habits of the country have changed and that medical problems have ensued as a result. Campaigns highlighting the risks of bad eating habits and promoting the benefits of healthy eating are becoming commonplace in Greece. These campaigns have caught the attention of many consumers and as a result, trends towards health and wellness have increased. Continued growth of these trends is likely to impact negatively on digestive remedies, as the number of consumers suffering from digestive ailments will decrease.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 43 Digestive Remedies Company Shares by Value 2006-2010
  • Table 44 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Greece - Category Analysis

TRENDS

  • Ear Care is an Rx category in Greece with no products available with an OTC status

Eye Care in Greece - Category Analysis

HEADLINES

TRENDS

  • The new list of OTC drugs, published in May 2010 by the Greek Ministry of Public Health, included the majority of standard eye care products, ceasing their reimbursement from the state. Before May, when consumers had to pay for only 25% of the retail price, the category was growing by nearly 3%; after May, when consumers had to pay for 100% of the retail price, value sales saw a significant decline. It is worth noting that during the summer, value sales declined by as much as 30%.

SWITCHES

COMPETITIVE LANDSCAPE

  • Alcon Laboratories Hellas Commercial & Industrial SA continued to lead eye care in 2010, with a retail value share of 42%, as it faced little competition, whilst Novartis (Hellas) SACI was ranked second with a retail value share of 22%. The star brand in Alcon Laboratories’ product range is Tears Naturale, which in 2010 was the leading brand in standard eye care, with retail value share of 41%.

PROSPECTS

  • Overexposure to television and computer screens, air conditioning and pollutants in urban environments are all becoming common features of everyday life in Greece. As a result, minor eye conditions such as eye dryness or eye redness are expected to become more prevalent. This fact as well as consumers’ willingness to self-medicate will ensure that eye care will retain a relatively stable performance over the forecast period, despite the general downturn.

CATEGORY DATA

  • Table 47 Sales of Eye Care by Category: Value 2005-2010
  • Table 48 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 49 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 50 Eye Care Company Shares by Value 2006-2010
  • Table 51 Eye Care Brand Shares by Value 2007-2010
  • Table 52 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 53 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Greece - Category Analysis

HEADLINES

TRENDS

  • Current health and wellness trends, evident across a wide range of consumer product categories, continued to benefit herbal/traditional healthcare products in 2010. Seen as a more natural and safe way to treat minor illnesses, herbal/traditional products were gaining in popularity over the review period.

COMPETITIVE LANDSCAPE

  • Cadbury Hellas continued to lead herbal/traditional products in Greece in 2010, claiming 22% share of value sales. This entire share comes from the company’s activity in herbal/traditional cough, cold and allergy (hay fever) remedies through its brands Halls and Halls Vita C. These products claim a substantial share of the medicated confectionery category within cough, cold and allergy (hay fever) remedies. This category experienced strong value sales and could be regarded as the most commercialised category of consumer health in Greece with many products on sale in grocery stores and kiosks.

PROSPECTS

  • The health and wellness trends in Greece which benefited herbal/traditional products are expected to accelerate over the forecast period. Consumers are likely to become increasingly aware of the benefits of a healthy lifestyle and also of the risks involved with the overconsumption of strong medicines for minor illnesses. Increasing numbers of consumers are therefore expected to look to herbal/traditional products when they first encounter illness before turning to stronger medicines if necessary.

CATEGORY DATA

  • Table 54 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 55 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 56 Herbal/Traditional Products Company Shares 2006-2010
  • Table 57 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 58 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 59 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Greece - Category Analysis

HEADLINES

TRENDS

  • The waiting for the much-anticipated new price list, which was published in September 2010, blocked medicated skin care for the greater part of the year. Unsure of future prices, manufacturers, and especially pharmacists, were very restrained in producing and stocking these products, and product shortages were not uncommon. No product developments could happen within this context, and the market seemed to stabilise only towards the end of the year, when the price list had been finally published.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson Hellas SA continued to lead medicated skin care in Greece in 2010 with a retail value share of 39% owing to the strength of its brands, such as Regaine in hair loss treatments and Johnson’s Baby and Penaten in nappy (diaper) rash treatments. The company also leads in medicated shampoo with Fungoral.

PROSPECTS

  • After a year of uncertainty regarding prices, which restrained the category and arrested new product developments, medicated skin care seems to be stabilising and returning to positive growth. Medicated skin care is thus expected to post a 1% value CAGR over the forecast period, with performance varying amongst different product categories. Another future trend, mostly notable in antiparasitics/lice treatments, is a slow but steady turn towards herbal/traditional products.

CATEGORY DATA

  • Table 60 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 61 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 62 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 63 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 64 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 65 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 66 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Greece - Category Analysis

HEADLINES

TRENDS

  • The smoking ban imposed on July 2009 ended up in complete failure, with the vast majority of premises around the country simply ignoring the law. The failure of the smoking ban led the government to implement a new and stricter ban on September 2010. According to the new law, smoking is forbidden in all public premises, with no exceptions whatsoever. However, the prospects of the new measure are not promising this time either. From the very first days following the implementation of the new law, associations of entertainment premises across the country openly criticised the ban, claiming that it would drive away their clientele, already in decline due to deteriorating economic conditions. Consumers themselves regularly sidestepped the new ban, and the fate of the law seemed uncertain once again.

SWITCHES

COMPETITIVE LANDSCAPE

  • Janssen-Cilag Pharmaceutical SACI continued to be the dominant player in NRT smoking cessation aids in 2010 with 98% share of value sales. Its brand Nicorette was the dominant brand over the entire review period, as it is the only brand that enjoys wide distribution and a high level of awareness amongst consumers.

PROSPECTS

  • The Greek government, in line with EU directives, has set the goal of decreasing smoking rates in the country. This will be accomplished through the implementation of tighter regulations, such as the implementation of the full smoking ban in 2010, as well as price increases on tobacco products, which were significant in 2010 and are announced to continue over the forecast period. However, a strong smoking culture and a tendency to sidestep unpopular laws undermine this effort, and it remains unclear to what extent the new measures will affect smoking rates.

CATEGORY INDICATORS

  • Table 67 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 68 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 69 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 70 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 71 NRT Smoking Cessation Aids Company Shares by Value 2006-2010
  • Table 72 NRT Smoking Cessation Aids Brand Shares by Value 2007-2010
  • Table 73 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 74 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in Greece - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition in Greece could be described as a stable category with little room for expansion. Sports nutrition products are widely regarded as solely body-enhancing products in Greece. The average consumer, however, is not particularly interested in building muscles and this fact, together with the specific, small target audience of athletes, is one of the reasons for the stability and lack of significant growth seen for sports nutrition. For these reasons, companies in sports nutrition in Greece attempted to focus on products which claimed to be performance enhancing and stamina improving rather than the more traditional muscle-building products.

COMPETITIVE LANDSCAPE

  • Twinlab Corp continued to be the leading company in sports nutrition in Greece in 2010, claiming a value share of 18%. This was only marginally ahead of Universal Nutrition Inc, which was ranked second also with a value share of 18%. Both companies carry a wide variety of sports nutrition products internationally and are represented in Greece predominantly through gyms and specialist sports equipment stores.

PROSPECTS

  • Manufacturers of sports nutrition have begun to take notice of current health and wellness trends in Greek society and it is expected that they will begin to focus their attention more and more in this direction in an effort to increase sales. By concentrating more on the possible health benefits of their products, they will hope to target a more mainstream consumer audience and begin to shift their image away from being just muscle-building products. This will be very much the case when it comes to future development of protein-based products, particularly in bar format, as these products are likely to be of greater appeal to mainstream consumers.

CATEGORY DATA

  • Table 75 Sports Nutrition, Category Rankings 2010
  • Table 76 Sales of Sports Nutrition: Value 2005-2010
  • Table 77 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 78 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 79 Sports Nutrition Company Shares 2006-2010
  • Table 80 Sports Nutrition Brand Shares 2007-2010
  • Table 81 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 82 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Greece - Category Analysis

HEADLINES

TRENDS

  • Price reductions and the economic recession were the most important factors affecting vitamins and dietary supplements in 2010. Despite current health trends favouring the expansion of the category, shrinking disposable income for the majority of Greek consumers led to a decline in volume sales of vitamins and dietary supplements, which are not considered as first-need, priority purchases. In addition, price reductions and special offers had a significant contribution to the decline of total value sales, which reached 6% in 2010. It must be noted that dietary supplements, which is more focused in terms of its target group and effects, outperformed vitamins.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Power Health Hellas led sales of vitamins and dietary supplements in 2010, claiming a value share of 12%, due to a high level of advertising both on television and in magazines. The success for Power Health Hellas is largely due to its focus on frequent product development and innovation as well as its wide variety and diversity of products. New products are rapidly brought to the attention of consumers through heavy advertising campaigns, especially in the form of in-store advertising such as posters and window displays in pharmacies.

PROSPECTS

  • The forecast performance of vitamins and dietary supplements as a whole, as well as the performance of individual categories, will greatly depend on the legal status of the products. According to the National Drug Organisation (EOF), all herbal products must have a medical file by April 2011 so that they are included in the official list of OTC drugs. Many companies had already handed in their files at the end of the review period, but it is uncertain when EOF will actually process them.

CATEGORY DATA

  • Table 83 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 84 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 85 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 86 Dietary Supplements by Positioning 2005-2010
  • Table 87 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 88 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 89 Vitamins Brand Shares by Value 2007-2010
  • Table 90 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 91 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 92 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Greece - Category Analysis

HEADLINES

TRENDS

  • Weight management began to see sales decline in 2010. Meal replacement slimming drove the decline in sales, recording a 2% drop in retail value terms. This drop of 2% was rather substantial as meal replacement slimming is by far the leading category in slimming products in Greece, worth €19 million and claiming a 77% value share of weight management in 2010. Much of the decline seen for meal replacement slimming came as a result of the poor long-term strategies of many companies active in the category. These strategies involved claimed rapid short-term profits with no real long-term plan. Over the review period, consumers began to realise that the claims made by many of these products were not entirely accurate, and the category’s image was seriously damaged as a result.

COMPETITIVE LANDSCAPE

  • In 2010, Prevent Hellas continued to be the leading company in terms of value sales with a 33% share. Herbalife International Greece ranked second with a 24% share, whilst Forever Living Products International ranked third with 14%. All of these companies are present within meal replacement slimming. The decline of this category, however, is likely to become a major concern for these companies and all three are expected to turn their attention towards weight loss supplements over the forecast period to retain share.

PROSPECTS

  • Increasing competition is expected to be the important story for weight management in Greece over the forecast period. The trend within weight management which saw consumers begin to move away from meal replacement products and towards weight loss supplements is expected to gather pace over the forecast period. In addition to this, increased competition will also come from the newly established category of OTC obesity, namely from Alli. External competition will come from the increasing number of fortified food products aimed at slimming, such as fortified cereals and low fat products.

CATEGORY DATA

  • Table 93 Sales of Weight Management: Value 2005-2010
  • Table 94 Sales of Weight Management: % Value Growth 2005-2010
  • Table 95 Weight Management Company Shares 2006-2010
  • Table 96 Weight Management Brand Shares 2007-2010
  • Table 97 Forecast Sales of Weight Management: Value 2010-2015
  • Table 98 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in Greece - Category Analysis

HEADLINES

TRENDS

  • The most prominent trend for 2010 is the turn of many consumers towards cheaper branded or private label products. Shrinking disposable income is forcing consumers to become increasingly price conscious and opt for cheaper solutions. However, industry officials believe that the shift towards economy variants is occurring as a form of trial, and consumers are likely to return to branded, added-value products. At the same time, a different trend is also occurring, favouring product specialisation, as consumers tend to choose the appropriate product for certain occasions, such as children’s products or plasters specialised for burns.

COMPETITIVE LANDSCAPE

  • Beiersdorf Hellas SA continued to lead wound treatments in 2010, with a retail value share of 64%. Beiersdorf Hellas SA is the manufacturer of the popular Hansaplast brand of various lines in sticking plasters and a spray format, all of which have developed significant loyalty and brand awareness in Greece. Hansaplast’s long-standing presence in Greece resulted in a brand name which is now commonly used as a generic term amongst consumers for sticking plasters.

PROSPECTS

  • Wound treatments in Greece could be regarded as rather mature category and as such, little room remains for considerable growth or expansion other than the expansion of specific products. Over the forecast period, the category is expected to demonstrate a minimal negative value CAGR. One large constraint to growth is that private label products are quickly expanding in times of shrinking disposable income. At the same time, the higher quality and the innovative features of branded variants, which offer high value for money, ensure that a part of the consumer base will return to, or insist on, buying branded variants such as Hansaplast. Thus value sales are not expected to further decline over the forecast period, but rather remain stable.

CATEGORY DATA

  • Table 99 Sales of Wound Care by Category: Value 2005-2010
  • Table 100 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 101 Wound Care Company Shares by Value 2006-2010
  • Table 102 Wound Care Brand Shares by Value 2007-2010
  • Table 103 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 104 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Aloe
            • Isoflavones
            • Spirulina
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Lecithin
            • Yeast
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

RELATED

Country Report

Consumer Lifestyle

Future Demographic

Country Report